Intrinsic Value of S&P & Nasdaq Contact Us

InfuSystem Holdings, Inc. INFU NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
78/100
5/7 Pass
SharesGrow Intrinsic Value
$18.65
+86.7%
Analyst Price Target
$15.00
+50.2%

InfuSystem Holdings, Inc. (INFU) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.

The consensus price target is $15.00, representing an upside of 50.2% from the current price $9.99.

Analysts estimate Earnings Per Share (EPS) of $0.14 and revenue of $0.14B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.11 vs est $0.14 (missed -22.8%). 2025: actual $0.32 vs est $0.29 (beat +10.3%). Analyst accuracy: 81%.

INFU Stock — 12-Month Price Forecast

$15.00
▲ +50.15% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for InfuSystem Holdings, Inc., the price target is $15.00.
The average price target represents a +50.15% change from the last price of $9.99.

INFU Analyst Ratings

Buy
3
Ratings
3 Buy
Based on 3 analysts giving stock ratings to InfuSystem Holdings, Inc. in the past 3 months
Rating breakdown
Buy
3 100%
100%
Buy
3 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — INFU

81%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.11 vs Est $0.14 ▼ 29.5% off
2025 Actual $0.32 vs Est $0.29 ▲ 9.4% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.

Revenue Estimates — INFU

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.135B vs Est $0.136B ▼ 0.8% off
2025 Actual $0.143B vs Est $0.144B ▼ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message